The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
ICD-10-CM Code. C79.31. Billable codes are sufficient justification for admission to an acute care hospital when used a principal diagnosis. C79.31 is a billable ICD code used to specify a diagnosis of secondary malignant neoplasm of brain. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
ICD-10 codes for metastatic spine tumors were C79.5 (secondary malignant neoplasm of the bone and marrow) and M49.50 (metastatic fracture of the vertebra, multiple sites in the spine). We categorized the surgeries into three types and placed patients into three surgical groups. These were the fusion, decompression, and vertebroplasty groups.
Secondary malignant neoplasm of unspecified site The 2022 edition of ICD-10-CM C79. 9 became effective on October 1, 2021.
Associated ICD-10-CM CodesMalignant neoplasm of bronchus and lungC34.90Malignant neoplasm of unspecified part of unspecified bronchus or lungC34.91Malignant neoplasm of unspecified part of right bronchus or lungC34.92Malignant neoplasm of unspecified part of left bronchus or lung18 more rows
Breast Cancer ICD-10 Code Reference SheetFEMALERightC50.811Malignant neoplasm of overlapping sites, right female breastC50.911Malignant neoplasm of unspecified site, right female breastD05.01Lobular carcinoma in situ, right breast9 more rows
Nonmalignant neoplasms of the lung are classified to code 212.3 for benign, 235.7 for uncertain behavior, and 239.1 for unspecified nature. If the lung cancer is considered a metastatic site—the cancer spread from another organ to the lung—code 197.0 is assigned.
If the site of the primary cancer is not documented, the coder will assign a code for the metastasis first, followed by C80. 1 malignant (primary) neoplasm, unspecified. For example, if the patient was being treated for metastatic bone cancer, but the primary malignancy site is not documented, assign C79. 51, C80.
ICD-10 code C50. 912 for Malignant neoplasm of unspecified site of left female breast is a medical classification as listed by WHO under the range - Malignant neoplasms .
A malignant neoplasm (NEE-oh-plaz-um) is another term for a cancerous tumor. The term “neoplasm” refers to an abnormal growth of tissue. The term “malignant” means the tumor is cancerous and is likely to spread (metastasize) beyond its point of origin.
Definition. A malignant tumor at the original site of growth. [ from NCI]
Cancer of the lung, squamous cell, stage 1. Cancer of the lung, squamous cell, stage 2. Cancer of the lung, squamous cell, stage 3. Cancer of the lung, squamous cell, stage 4. Cancer, lung, non small cell. Eaton-lambert syndrome due to small cell carcinoma of lung. Eaton-lambert syndrome due to small cell lung cancer.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Cancer that forms in tissues of the lung, usually in the cells lining air passages. The two main types are small cell lung cancer and non-small cell lung cancer. These types are diagnosed based on how the cells look under a microscope.
The 2022 edition of ICD-10-CM C34.90 became effective on October 1, 2021.
The 2022 edition of ICD-10-CM C79.51 became effective on October 1, 2021.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
Thyroid cancer metastatic to bone. Clinical Information. Cancer that has spread from the original (primary) tumor to the bone. The spread of a malignant neoplasm from a primary site to the skeletal system. The majority of metastatic neoplasms to the bone are carcinomas.
secondary carcinoid tumors ( C 7B.-) secondary neuroendocrine tumors ( C7B.-) Cancer that has spread from the original (primary) tumor to the bone.
secondary carcinoid tumors ( C7B.-) secondary neuroendocrine tumors ( C7B.-) Cancer that has spread from the original (primary) tumor to the bone. The spread of a malignant neoplasm from a primary site to the skeletal system.